Rare diseases
Investigational molecules
Locations
Back to Austria142 clinical trials in St. Poelten, Austria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
AustriaStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease
AustriaStudy of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation
AustriaStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
AustriaStudy on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin
AustriaStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
AustriaStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
AustriaStudy on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis
AustriaStudy of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema
AustriaStudy on the Effectiveness and Safety of AP707 and Naproxen for Patients with Chronic Back Pain
AustriaStudy on the Effectiveness and Safety of AP707 with Lamotrigine and Amitriptyline for Patients with Chronic Central Neuropathic Pain
AustriaStudy on the Effectiveness of AP707, Gabapentin, and Capsaicin for Patients with Chronic Pain from Traumatic or Post-Operative Peripheral Neuropathy
AustriaThe busiest research cities in the country
What the registry says about research in the country
The cardiovascular diseases research activity in St. Pölten focuses on improving outcomes for people with high-risk heart and vascular conditions. Trials are examining whether new approaches can better reduce major cardiovascular events and ease the burden of complex heart disease.
These studies aim to test treatment effectiveness and lower the risk of serious complications in patients with difficult-to-manage cardiovascular conditions.
Research in eye diseases is centered on neovascular age-related macular degeneration, with an emphasis on making care more practical in everyday clinical settings. The work reflects a strong interest in improving how patients are monitored and treated.
In St. Pölten, this area of research is helping evaluate ways to support better eye care while reducing treatment burden for patients and clinics.
Immune system diseases are represented by trials in allergic rhinoconjunctivitis and chronic hepatitis D infection. These studies are exploring new options to manage immune-related conditions and improve symptom control.
The research is designed to assess whether emerging therapies can offer better relief or disease control for patients living with persistent immune-driven illnesses.
Neoplasm research in St. Pölten spans both solid tumors and advanced cancer care, including studies in melanoma, hepatocellular carcinoma, and metastatic pancreatic ductal adenocarcinoma. The goal is to improve treatment effectiveness and survival in cancers that can be hard to treat.
These trials are testing new cancer treatment strategies and comparing them with established care to find better options for patients.
Work in virus diseases is addressing chronic hepatitis D, a serious viral infection that can lead to long-term liver damage. The studies are focused on finding more effective ways to control the disease.
This area of research is aimed at evaluating new therapies against current treatment options and improving care for patients with persistent viral illness.
Clinical trials in psychiatry and psychology are centered on mild to moderate major depressive disorder. The research is looking at whether new treatment options can better reduce depressive symptoms and support recovery.
These studies are intended to clarify treatment benefit and help identify therapies that may offer meaningful relief for people living with depression.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
